# US 2024/0002841 A1 · Means and methods for modifying multiple alleles

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2024/0002841 A1
- Document ID: US20240002841A1
- Status: Published application
- Kind: A1
- Application number: 18/329,503
- Filed: 2023-06-05
- Published: 2024-01-04
- Earliest claimed: 2016-06-20
- Assignees: Octapharma AG
- Applicants: Octapharma AG
- Inventors: Karina Nawrath; Janine Guendel; Sven Bahrke; Lars Stoeckl; Steffen Goletz
- Web page: https://patentgrep.com/patent/US20240002841A1

## CPC

- C12N 15/11: DNA or RNA fragments; Modified forms thereof (DNA or RNA not used in recombinant technology, C07H21/00); {Non-coding nucleic acids having a biological activity}
- C12N 9/22: Ribonucleases {[RNase]; Deoxyribonucleases [DNase]}
- C12N 9/6437: {Coagulation factor VIIa (3.4.21.21)}
- C12N 15/102: {Mutagenizing nucleic acids}
- C12P 21/005: {Glycopeptides, glycoproteins}
- C12Y 304/21021: Coagulation factor VIIa (3.4.21.21)
- C12N 15/1137: {against enzymes (viral enzymes C12N15/1131; receptors C12N15/1138)}
- C12N 2310/20: involving clustered regularly interspaced short palindromic repeats [CRISPR]
- C12N 2800/80: Vectors containing sites for inducing double-stranded breaks, e.g. meganuclease restriction sites
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)
- C12P: FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE {(brewing of beer C12C; producing vinegar C12J; producing specific peptides or proteins C07K; producing enzymes C12N9/00; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification C12N15/00; measuring or testing processes involving enzymes or microorganisms C12Q; measuring or testing processes involving nucleic acid amplification reactions C12Q1/6844; fermentation processes to form a food composition, A21 or A23; compounds in general, see the relevant compound class, e.g. C01, C07)}
- C12Y: ENZYMES

## Abstract

The present invention relates to a method of modifying at least one gene in a cell via CRISPR/Cas, wherein the at least one gene has at least three alleles. The present invention further relates to cells obtainable by the method of the invention. Additionally, the present invention provides a method of producing a protein in a cell obtainable by the method of modifying at least one gene of the invention. Moreover, the invention relates to proteins obtainable by the method of producing a protein and use thereof, for example in therapy.

## Claims

### Claim 1

A method of modifying at least one gene in a cell via CRISPR/Cas, wherein the at least one gene has at least three alleles.

### Claim 2 (depends on 1)

The method of claim 1, wherein at least two genes are modified, wherein at least one of the two genes has at least three alleles.

### Claim 3 (depends on 1)

The method of claim 1, wherein at least two genes are modified, and wherein a first gene has at least three alleles and a second gene has at least three alleles, preferably four alleles.

### Claim 4 (depends on 1)

The method of claim 1 wherein at least one, two, three, four or all alleles of the at least one gene, preferably of the at least two genes, are modified.

### Claim 5 (depends on 1)

The method of claim 1, wherein the at least one gene or the at least two genes is/are targeted in at least one, preferably in two, position(s) of the nucleotide sequence of its/their coding and/or regulatory region(s).

### Claim 6 (depends on 1)

The method of claim 1, wherein the cell is polyploid in at least one gene, preferably in at least one of the genes to be modified.

### Claim 7 (depends on 1)

The method of claim 1, wherein the cell is diploid, triploid or tetraploid in at least one of the genes.

### Claim 8 (depends on 1)

The method of claim 1, wherein the cell is triploid in a first gene and tetraploid in a second gene, preferably wherein the first gene and/or the second gene are to be modified.

### Claim 9 (depends on 1)

The method of claim 1, wherein modifying at least one gene via CRISPR/Cas results in introduction of one or more insertion(s), deletion(s) and/or substitution(s) of one or more nucleotides or a combination thereof in a coding and/or regulatory region of the at least one gene.

### Claim 10 (depends on 1)

The method of claim 1, wherein modifying at least one gene via CRISPR/Cas results in decreased transcription and/or expression of the least one gene and/or in production of a variant of the at least one gene which is truncated and/or has altered enzymatic activity.

### Claim 11 (depends on 1)

The method according to claim 1, wherein the cell is a human cell or is derived from a human cell.

### Claim 12 (depends on 1)

The method according to claim 1, wherein the cell is an immortalized cell.

### Claim 13 (depends on 1)

The method according to claim 1, wherein for each position to be targeted the CRISPR/Cas system comprises two gRNA plasmids, each gRNA plasmid comprising a specific targeting sequence.

### Claim 14 (depends on 1)

The method according to claim 1, wherein the at least one gene is B4GALNT3, B4GALNT4 or glutamine synthetase.

### Claim 15 (depends on 2)

The method according to claim 2, wherein the at least two genes are B4GALNT3 and B4GALNT4, preferably wherein the first gene is B4GALNT3 and the second gene is B4GALNT4.

### Claim 16 (depends on 15)

The method according to claim 15, wherein B4GALNT3 and B4GALNT4 are each targeted in two positions.

### Claim 17 (depends on 14)

The method according to claim 14, wherein the targeting sequences specific for B4GALNT3 are selected from ATTGCTGCAGATGACAACG (SEQ ID NO: 1)/TGGATTTTCCCTGGGCAGC (SEQ ID NO: 2) and CCCGGGACACCCTCTATCG (SEQ ID NO: 3)/GGCCGAAGCATGTCAGCGGG (SEQ ID NO: 4); and/or wherein the targeting sequences specific for B4GALNT4 are selected from GCGTGCACTTGTGTATTCG (SEQ ID NO: 5)/CCACAGTCACTCACCGCCT (SEQ ID NO: 6) and GGTTTCATCCACCCGGCGA (SEQ ID NO: 7)/GAGTCCATAGTTCTTCCACT (SEQ ID NO: 8).

### Claim 18 (depends on 1)

A cell obtainable by the method of claim 1.

### Claim 19 (depends on 18)

A method of producing a protein in a host cell, comprising the steps of:
introducing at least one nucleic acid encoding said protein in a cell according to claim 18;
culturing said host cell under conditions which permit the production of said protein; thereby producing the protein.

### Claim 20 (depends on 19)

The method of producing a protein according to claim 19, wherein the protein is a naturally occurring protein, an artificially created protein or a fragment thereof.
